Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at the global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Bifidobacterium industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Product trends
2.4 Application trends
2.5 End-use trends
2.6 Distribution channel trends
2.7 Regional trends
Chapter 3 Bifidobacterium Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising demand for probiotic products
3.2.1.2 Growing interest in personalized nutrition
3.2.1.3 Innovations in delivery formats
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory challenges
3.2.2.2 Shelf stability & viability
3.2.2.3 Product formulation & compatibility
3.3 Growth potential analysis
3.3.1 By product
3.3.2 By application
3.3.3 By end use
3.3.4 By distribution channel
3.4 COVID-19 impact analysis
3.5 Impact of Russia Ukraine war
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Pricing analysis, 2022
3.8 Reimbursement scenario
3.9 Technology landscape
3.10 Future market trends
3.11 Porter's analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Bifidobacterium Market Size and Forecast, By Product 2018 - 2032
5.1 Key trends, by product
5.2 Bifidobacterium longum
5.3 Bifidobacterium breve
5.4 Bifidobacterium infantis
5.5 Bifidobacterium animalis
5.6 Bifidobacterium lactis
5.7 Other Bifidobacterium strains
Chapter 6 Bifidobacterium Market Size and Forecast, By Application 2018 - 2032
6.1 Key trends, by application
6.2 Dietary Supplements
6.3 Functional Foods and Beverages
6.4 Animal Feed
6.5 Pharmaceuticals
6.6 Others
Chapter 7 Bifidobacterium Market Size and Forecast, By End Use 2018 - 2032
7.1 Key trends, by end use
7.2 Adults
7.3 Children
7.4 Infants
7.5 Animals
Chapter 8 Bifidobacterium Market Size and Forecast, By Distribution Channel 2018 - 2032
8.1 Key trends, by distribution channel
8.2 Online retail
8.3 Supermarkets
8.4 Health Stores
8.5 Pharmacies
8.6 Others
Chapter 9 Bifidobacterium Market Size and Forecast, By Region 2018 - 2032
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Malaysia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Egypt
Chapter 10 Company Profiles
10.1 DuPont de Nemours, Inc.
10.2 Chr. Hansen Holding A/S
10.3 Lallemand Inc.
10.4 Kerry Group
10.5 Probi AB
10.6 Morinaga Milk Industry Co., Ltd.
10.7 Yakult Honsha Co., Ltd.
10.8 Nestlé S.A.
10.9 Danone S.A.
10.10 Bifodan A/S
10.11 Ganeden Biotech
10.12 BioGaia AB
10.13 Sabinsa Corporation
10.14 Lallemand Inc.
10.15 Biocare Copenhagen A/S
